276 related articles for article (PubMed ID: 34169795)
1. Cardiometabolic health in premature ovarian insufficiency.
Stevenson JC; Collins P; Hamoda H; Lambrinoudaki I; Maas AHEM; Maclaran K; Panay N
Climacteric; 2021 Oct; 24(5):474-480. PubMed ID: 34169795
[TBL] [Abstract][Full Text] [Related]
2. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study.
Gunning MN; Meun C; van Rijn BB; Daan NMP; Roeters van Lennep JE; Appelman Y; Boersma E; Hofstra L; Fauser CGKM; Rueda-Ochoa OL; Ikram MA; Kavousi M; Lambalk CB; Eijkemans MJC; Laven JSE; Fauser BCJM;
PLoS One; 2020; 15(3):e0229576. PubMed ID: 32134933
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
Sullivan SD; Sarrel PM; Nelson LM
Fertil Steril; 2016 Dec; 106(7):1588-1599. PubMed ID: 27912889
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Risk in Women With Premature Ovarian Insufficiency Compared to Premenopausal Women at Middle Age.
Daan NM; Muka T; Koster MP; Roeters van Lennep JE; Lambalk CB; Laven JS; Fauser CG; Meun C; de Rijke YB; Boersma E; Franco OH; Kavousi M; Fauser BC
J Clin Endocrinol Metab; 2016 Sep; 101(9):3306-15. PubMed ID: 27300572
[TBL] [Abstract][Full Text] [Related]
5. Understanding of and clinical approach to cardiometabolic transition at the menopause.
Lambrinoudaki I; Armeni E
Climacteric; 2024 Feb; 27(1):68-74. PubMed ID: 37224871
[TBL] [Abstract][Full Text] [Related]
6. Premature ovarian insufficiency, early menopause, and induced menopause.
Hamoda H; Sharma A
Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101823. PubMed ID: 37802711
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Risk Factors in Premature Ovarian Insufficiency using Hormonal Therapy.
Rezende GP; Dassie T; Gomes DAY; Benetti-Pinto CL
Rev Bras Ginecol Obstet; 2023 Jun; 45(6):312-318. PubMed ID: 37494573
[TBL] [Abstract][Full Text] [Related]
8. Use of Hormone Therapy in Women with Early Menopause and Premature Ovarian Insufficiency.
Lersten I; Clain E; Santoro N
Semin Reprod Med; 2020 Sep; 38(4-05):302-308. PubMed ID: 33540459
[TBL] [Abstract][Full Text] [Related]
9. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
10. Premature and Early Menopause in Relation to Cardiovascular Disease.
Schipper I; Louwers YV
Semin Reprod Med; 2020 Sep; 38(4-05):270-276. PubMed ID: 33511582
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
Armeni E; Paschou SA; Goulis DG; Lambrinoudaki I
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101561. PubMed ID: 34274232
[TBL] [Abstract][Full Text] [Related]
12. Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis.
Cai WY; Luo X; Wu W; Song J; Xie NN; Duan C; Wu XK; Xu J
J Ovarian Res; 2022 Sep; 15(1):109. PubMed ID: 36180908
[TBL] [Abstract][Full Text] [Related]
13. Premature ovarian insufficiency: a toolkit for the primary care physician.
Lambrinoudaki I; Paschou SA; Lumsden MA; Faubion S; Makrakis E; Kalantaridou S; Panay N
Climacteric; 2021 Oct; 24(5):425-437. PubMed ID: 33434082
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Gislinge JIP; Thomsen CW; Ravn P
Ugeskr Laeger; 2023 Jul; 185(28):. PubMed ID: 37539798
[TBL] [Abstract][Full Text] [Related]
15. Demographic, clinical and hormonal characteristics of patients with premature ovarian insufficiency and those of early menopause: data from two tertiary premature ovarian insufficiency centers in Greece.
Bompoula MS; Valsamakis G; Neofytou S; Messaropoulos P; Salakos N; Mastorakos G; Kalantaridou SN
Gynecol Endocrinol; 2020 Aug; 36(8):693-697. PubMed ID: 32208770
[TBL] [Abstract][Full Text] [Related]
16. Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy.
Upton CE; Daniels JP; Davies MC
Climacteric; 2021 Oct; 24(5):453-458. PubMed ID: 33928827
[TBL] [Abstract][Full Text] [Related]
17. Primary ovarian insufficiency: relation to changes in body composition and adiposity.
Michalakis K; Coppack SW
Maturitas; 2012 Apr; 71(4):320-5. PubMed ID: 22300684
[TBL] [Abstract][Full Text] [Related]
18. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls.
Ates S; Yesil G; Sevket O; Molla T; Yildiz S
Maturitas; 2014 Nov; 79(3):306-10. PubMed ID: 25085705
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profile of women with premature ovarian insufficiency compared with that of age-matched healthy controls.
Huang Y; Lv Y; Qi T; Luo Z; Meng X; Ying Q; Li D; Li C; Lan Y; Chu K; Fu D; Chen P; Xu W; Jia Y; Li S; Cen X; Li L; Xu L; Ma L; Zhou J
Maturitas; 2021 Jun; 148():33-39. PubMed ID: 34024349
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell-specific-molecule-1 (endocan) levels in women with premature ovarian insufficiency: a prospective comparative study.
Ovayolu A; Karaman E; Turgut A; Cekici Y; Ortabag T; Chiara Rapisarda AM; Noventa M; Cianci A
J Obstet Gynaecol; 2021 May; 41(4):637-641. PubMed ID: 32808833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
